Cargando…
Acceptability of a ‘treat to target’ approach in inflammatory bowel disease to patients in clinical remission
BACKGROUND: A ‘treat to target’ approach aiming for remission of clinical symptoms and absence of mucosal inflammation has been proposed in inflammatory bowel disease (IBD). We aimed to establish whether patients with IBD in clinical remission find this approach acceptable. METHODS: Patients in gluc...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802490/ https://www.ncbi.nlm.nih.gov/pubmed/33493249 http://dx.doi.org/10.1136/flgastro-2019-101366 |